Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900023151Phase 4Not yet recruiting
Phase 4, open-label trial of dyclonine and tetracaine in None (2 arms), sponsored by First Medical Center of Chinese PLA General Hospital. Primary endpoint: Mean arterial pressure. Planned start Jan 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900023151.